Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,229
+$2,430 QoQ
Shares Held
34
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#758
of 844 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fairscale Capital, LLC holds $1,487,293 across 7 Diagnostics & Research names. NTRA ranks #5 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,327 | $1,166,664 | |
| 2 | DHR |
Danaher Corp /De/
|
1,311 | $249,719 | |
| 3 | LH |
Labcorp Holdings Inc.
|
166 | $46,480 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
25 | $13,239 | |
| 5 | NTRA |
Natera, Inc.
This page
|
34 | $9,229 | |
| 6 | ILMN |
Illumina, Inc.
|
10 | $1,758 | |
| 7 | GRAL |
GRAIL, Inc.
|
3 | $204 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,229 | 34 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,799 | 34 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,789 | 34 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,472 | 34 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,743 | 34 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||